Back
Voyager Therapeutics Vs. Neurocrine Biosciences Industry Stock Comparison
Sell
44
VYGR
Voyager Therapeutics
Last Price:
7.76
Seasonality Move:
7.86%
Buy
64
NBIX
Neurocrine Biosciences
Last Price:
133.30
Seasonality Move:
9.97%
Sell
44
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $7.97. The Score for VYGR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VYGR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $132.99. The Score for NBIX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $7.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing selling pressure, which indicates risk of future bearish movement.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $132.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.
VYGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 38.16 | Sell |
Chaikin Money Flow: | -317918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.66 - 9.84) | Sell |
Bollinger Bands (100): | (7.36 - 9.28) | Sell |
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 39.74 | Sell |
Chaikin Money Flow: | -192957 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.95 - 141.33) | Sell |
Bollinger Bands (100): | (123.48 - 140.88) | Buy |
VYGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.72 | Sell |
20-day SMA: | 9.28 | Sell |
50-day SMA: | 8.74 | Sell |
200-day SMA: | 8.34 | Sell |
8-day EMA: | 8.62 | Sell |
20-day EMA: | 8.96 | Sell |
50-day EMA: | 8.81 | Sell |
200-day EMA: | 8.38 | Sell |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 136.36 | Sell |
20-day SMA: | 138.44 | Sell |
50-day SMA: | 136.55 | Sell |
200-day SMA: | 119.78 | Buy |
8-day EMA: | 135.41 | Sell |
20-day EMA: | 137 | Sell |
50-day EMA: | 136.13 | Sell |
200-day EMA: | 123.63 | Buy |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $3.25 per share, and an increase next year of $0.04 per share.
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.86 per share, and an increase next year of $1.78 per share.
Voyager Therapeutics Technical Analysis
Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurocrine Biosciences Technical Analysis
Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |